logo

Cytodyn Inc. (CYDY.OB)



Trade CYDY.OB now with
  Date
  Headline
5/27/2021 6:22:19 AM CytoDyn: Biomm Plans To Submit Authorization To Conduct Phase 3 Clinical Studies Of Leronlimab
4/5/2021 6:25:36 AM CytoDyn Completes An Additional Potentially Non-dilutive Convertible Debt Offering
4/1/2021 6:04:37 AM CytoDyn Files New Protocol With FDA For 4 Doses Of Leronlimab For Critically Ill COVID-19 Patients
3/30/2021 6:06:36 AM CytoDyn Announces Further Results From CD12 Trial Of Severe-to-critically Ill Patients With COVID-19
3/29/2021 6:08:45 AM CytoDyn: The Philippines FDA Approves Use Of Leronlimab To Treat COVID-19 Patient